 Jonathan Lindquist
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Artery Embolization | 2 | 2021 | 9 | 0.820 |
Why?
| | Thrombolytic Therapy | 5 | 2025 | 163 | 0.690 |
Why?
| | Vena Cava Filters | 4 | 2025 | 64 | 0.680 |
Why?
| | Pulmonary Embolism | 5 | 2025 | 244 | 0.660 |
Why?
| | Postpartum Hemorrhage | 1 | 2021 | 28 | 0.660 |
Why?
| | Radiography, Interventional | 2 | 2024 | 130 | 0.660 |
Why?
| | Thrombectomy | 4 | 2024 | 78 | 0.650 |
Why?
| | Venous Thrombosis | 4 | 2024 | 195 | 0.500 |
Why?
| | Postthrombotic Syndrome | 3 | 2024 | 13 | 0.460 |
Why?
| | Device Removal | 4 | 2025 | 143 | 0.320 |
Why?
| | Fibrinolytic Agents | 3 | 2025 | 292 | 0.280 |
Why?
| | Iliac Vein | 2 | 2024 | 15 | 0.250 |
Why?
| | Femoral Vein | 2 | 2024 | 38 | 0.250 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2026 | 14 | 0.240 |
Why?
| | Yttrium Radioisotopes | 1 | 2026 | 64 | 0.230 |
Why?
| | Vascular Access Devices | 1 | 2025 | 30 | 0.230 |
Why?
| | Treatment Outcome | 10 | 2026 | 11695 | 0.210 |
Why?
| | Tissue Plasminogen Activator | 1 | 2025 | 244 | 0.200 |
Why?
| | Podocytes | 1 | 2023 | 80 | 0.190 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2026 | 372 | 0.180 |
Why?
| | Anticoagulants | 2 | 2024 | 724 | 0.180 |
Why?
| | Geriatrics | 1 | 2023 | 96 | 0.180 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 94 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2024 | 300 | 0.170 |
Why?
| | Registries | 2 | 2026 | 2385 | 0.160 |
Why?
| | Venous Thromboembolism | 1 | 2024 | 324 | 0.150 |
Why?
| | Kidney Diseases | 1 | 2023 | 427 | 0.150 |
Why?
| | Liver Neoplasms | 1 | 2026 | 783 | 0.150 |
Why?
| | Dementia | 1 | 2023 | 304 | 0.140 |
Why?
| | Radial Artery | 1 | 2018 | 70 | 0.130 |
Why?
| | Leiomyoma | 1 | 2018 | 59 | 0.130 |
Why?
| | Mitochondria | 1 | 2024 | 984 | 0.130 |
Why?
| | Sodium Chloride | 1 | 2018 | 142 | 0.130 |
Why?
| | Uterine Neoplasms | 1 | 2018 | 97 | 0.130 |
Why?
| | Mice, Knockout | 1 | 2024 | 3125 | 0.130 |
Why?
| | Catheterization, Peripheral | 1 | 2018 | 119 | 0.120 |
Why?
| | Thromboembolism | 1 | 2017 | 125 | 0.120 |
Why?
| | Peripheral Arterial Disease | 1 | 2022 | 503 | 0.110 |
Why?
| | Prosthesis Design | 1 | 2017 | 357 | 0.110 |
Why?
| | Ischemia | 1 | 2018 | 421 | 0.110 |
Why?
| | Aged | 8 | 2026 | 25947 | 0.110 |
Why?
| | Aged, 80 and over | 4 | 2026 | 8279 | 0.090 |
Why?
| | Female | 10 | 2026 | 78376 | 0.090 |
Why?
| | Humans | 15 | 2026 | 144957 | 0.090 |
Why?
| | Male | 10 | 2026 | 72406 | 0.080 |
Why?
| | Risk Factors | 4 | 2025 | 10792 | 0.080 |
Why?
| | Middle Aged | 7 | 2026 | 35928 | 0.080 |
Why?
| | Medicare | 2 | 2025 | 887 | 0.070 |
Why?
| | Prospective Studies | 3 | 2026 | 7997 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7191 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2884 | 0.060 |
Why?
| | Logistic Models | 2 | 2024 | 2119 | 0.060 |
Why?
| | Single Photon Emission Computed Tomography Computed Tomography | 1 | 2026 | 15 | 0.060 |
Why?
| | Kidney | 2 | 2024 | 1496 | 0.060 |
Why?
| | Microspheres | 1 | 2026 | 142 | 0.060 |
Why?
| | Cholangiocarcinoma | 1 | 2026 | 106 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2024 | 75 | 0.050 |
Why?
| | Cold-Shock Response | 1 | 2023 | 3 | 0.050 |
Why?
| | Equipment Design | 1 | 2025 | 530 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 7183 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2026 | 6434 | 0.050 |
Why?
| | Vascular Patency | 1 | 2023 | 121 | 0.050 |
Why?
| | United States | 3 | 2026 | 15988 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 89 | 0.050 |
Why?
| | Atherectomy | 1 | 2022 | 37 | 0.050 |
Why?
| | Cohort Studies | 2 | 2023 | 5965 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 169 | 0.050 |
Why?
| | Inflammasomes | 1 | 2023 | 146 | 0.040 |
Why?
| | Quality of Life | 2 | 2025 | 3192 | 0.040 |
Why?
| | Propensity Score | 1 | 2024 | 367 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 276 | 0.040 |
Why?
| | Infant | 2 | 2026 | 10039 | 0.040 |
Why?
| | Femoral Artery | 1 | 2022 | 190 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2025 | 17101 | 0.040 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 81 | 0.040 |
Why?
| | Child, Preschool | 2 | 2026 | 11799 | 0.040 |
Why?
| | Adult | 4 | 2026 | 40506 | 0.040 |
Why?
| | Length of Stay | 1 | 2024 | 1337 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2023 | 544 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2024 | 1126 | 0.030 |
Why?
| | Incidence | 1 | 2024 | 2883 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2024 | 1500 | 0.030 |
Why?
| | Age Factors | 1 | 2024 | 3335 | 0.030 |
Why?
| | Ultrasonography, Interventional | 1 | 2018 | 160 | 0.030 |
Why?
| | Mice | 2 | 2024 | 18365 | 0.030 |
Why?
| | History, 20th Century | 1 | 2017 | 325 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1742 | 0.030 |
Why?
| | Adolescent | 2 | 2026 | 22453 | 0.030 |
Why?
| | Child | 2 | 2026 | 22657 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5417 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4569 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5997 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2880 | 0.020 |
Why?
| | Animals | 2 | 2024 | 38109 | 0.020 |
Why?
| | Young Adult | 1 | 2026 | 14126 | 0.020 |
Why?
|
|
Lindquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|